Literature DB >> 17122098

A novel imaging technique for experimental choroidal neovascularization.

Mercedes Campos1, Juan Amaral, S Patricia Becerra, Robert N Fariss.   

Abstract

PURPOSE: Choroidal neovascularization (CNV) is the end point of several ocular diseases that lead to blindness. The authors developed an imaging technique for visualizing and quantifying morphologic changes associated with experimental laser-induced CNV.
METHODS: CNV was induced using laser energy to disrupt Bruch's membrane. Rats were euthanatized immediately after laser injury and at 1, 2, 3, 4, 7, 14, and 60 days. Nonlasered eyes were used as the control. Eyes were enucleated and fixed, and the posterior eye cups were fluorescently labeled with markers for nuclei (DAPI; 4',6'-diamino-2-phenylindole), endothelial cells (isolectin IB4), microglia (CD11b), and filamentous actin (phalloidin). FITC-dextran perfusion was compared with our technique. A confocal microscope was used to evaluate flatmounted specimens. Computer software generated three-dimensional reconstructions for qualitative and quantitative analysis of confocal image stacks.
RESULTS: In nonlasered areas, RPE cells were visualized as a uniform hexagonal array. Immediately after laser exposure, a circular area devoid of fluorescent labeling was observed, indicating disruption of the choroid-Bruch's membrane-RPE complex. One day after laser exposure, cellular debris and fragmented nuclei were present, and an autofluorescent ring was visible at the site of Bruch's membrane disruption. The ring correlated with bubble formation and CNV induction. Three days after laser injury, phalloidin-labeled RPE cells and isolectin-labeled endothelial cells increased significantly, reflecting cell proliferation and migration. By day 4, isolectin-positive cells forming vascular tubes were visualized. The volume of CNV vessels increased exponentially during the next 3 days. By 7 days, a well-defined isolectin-labeled CNV network was present, and its volume was preserved for several weeks. CNV volumes calculated on the basis of FITC-dextran perfusion were significantly lower than volumes obtained using lectin-labeled samples.
CONCLUSIONS: A novel imaging technique was developed that allows a three-dimensional reconstruction and measurement of laser-induced CNV lesions in rat choroid/RPE flatmounts. This technique provides excellent morphologic detail and facilitates the study of critical early events in CNV, including the rupture of Bruch's membrane and the formation of endothelial clusters before vessel formation. CNV complexes are labeled at an earlier stage and more reproducibly than with FITC-dextran perfusion, providing a more accurate preclinical evaluation of antiangiogenic molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122098     DOI: 10.1167/iovs.06-0156

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

2.  Assays for the antiangiogenic and neurotrophic serpin pigment epithelium-derived factor.

Authors:  Preeti Subramanian; Susan E Crawford; S Patricia Becerra
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

3.  Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.

Authors:  Jyotirmoy Kusari; Edwin Padillo; Sheila X Zhou; Yanyan Bai; Juanjuan Wang; Zhiming Song; Meili Zhu; Yun-Zheng Le; Daniel W Gil
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-20       Impact factor: 4.799

4.  Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents.

Authors:  Sara Moghaddam-Taaheri; Monica Agarwal; Juan Amaral; Irina Fedorova; Elvira Agrón; Norman Salem; Emily Chew; S Patricia Becerra
Journal:  J Clin Exp Ophthalmol       Date:  2011-10-23

5.  Sterculic acid antagonizes 7-ketocholesterol-mediated inflammation and inhibits choroidal neovascularization.

Authors:  Jiahn-Dar Huang; Juan Amaral; Jung Wha Lee; Ignacio M Larrayoz; Ignacio R Rodriguez
Journal:  Biochim Biophys Acta       Date:  2012-02-08

6.  A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection.

Authors:  Takayuki Baba; Imran A Bhutto; Carol Merges; Rhonda Grebe; David Emmert; D Scott McLeod; Donald Armstrong; Gerard A Lutty
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

7.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

8.  Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model.

Authors:  Jaeryung Kim; Tae Eun Kim; Ju-A Kim; Ji-Hyun Yun; Seongsoo Sohn; Sang Ryeol Shim; Sang Hoon Lee; Sang Jin Kim
Journal:  J Ocul Pharmacol Ther       Date:  2014-12       Impact factor: 2.671

9.  Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.

Authors:  Anil Kumar; Xu Hou; Chunsik Lee; Yang Li; Arvydas Maminishkis; Zhongshu Tang; Fan Zhang; Harald F Langer; Pachiappan Arjunan; Lijin Dong; Zhijian Wu; Linda Y Zhu; Lianchun Wang; Wang Min; Peter Colosi; Triantafyllos Chavakis; Xuri Li
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

10.  Doxycycline-mediated inhibition of choroidal neovascularization.

Authors:  Sonia Samtani; Juan Amaral; Maria M Campos; Robert N Fariss; S Patricia Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-10       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.